Revelation Biosciences, Inc. (REVB)
NASDAQ·Healthcare·Biotechnology
$1.00
-0.99%
Mkt Cap $1.90M
No analyst coverage available
We don't have analyst ratings or price target data for Revelation Biosciences, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.